[New - 7 Covid-19 Realities To Consider In 2023](https://wbbsec.com/opinions-and-features/)
[New - 7 Covid-19 Realities To Consider In 2023](https://wbbsec.com/opinions-and-features/)
powered by bulletin
In: Press Releases

For Immediate Release

Jan. 10, 2022

Cranford, NJ – WBB Securities is a sponsor of this year’s Biotech Showcase. The conference is taking place for the fourteenth consecutive year. It was scheduled to take place in San Francisco, after careful consideration they have made the decision to deliver Biotech Showcase in a 100% virtual format, given the ongoing developments with the COVID-19 pandemic.

This rapidly growing conference features multiple tracks of curated presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings using the industry’s gold-standard platform, partneringONE®.

In addition to biopharmaceutical and life science company executives, Biotech Showcase delegates include investors in private and public companies, sector analysts, bankers, and industry professionals.

The event dates are, January 10–12, 2022 and January 17–19, 2022

Click here to register.

About WBB Securities.

WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused primarily in the life sciences niche. Established in 2001 with offices in New Jersey, New York, and California. WBB Securities is registered with the SEC as a broker-dealer and is a member of FINRA, as well as a state-registered investment advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients.


About Demy-Colton and EBD Group

Both organizations have a combined history of over 50 years in producing high quality programs that support the growth of the biotechnology and broader life sciences industry.